Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?
Gerard Sanacora, Alan F. Schatzberg
Neuropsychopharmacology (2014) Vol. 40, Iss. 2, pp. 259-267
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman, George K. Aghajanian, Gerard Sanacora, et al.
Nature Medicine (2016) Vol. 22, Iss. 3, pp. 238-249
Open Access | Times Cited: 1363
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport, Linda L. Carpenter, William M. McDonald, et al.
American Journal of Psychiatry (2015) Vol. 172, Iss. 10, pp. 950-966
Open Access | Times Cited: 543
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Roger S. McIntyre, Joshua D. Rosenblat, Charles B. Nemeroff, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 5, pp. 383-399
Open Access | Times Cited: 487
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan Williams, Boris D. Heifets, Christine Blasey, et al.
American Journal of Psychiatry (2018) Vol. 175, Iss. 12, pp. 1205-1215
Open Access | Times Cited: 418
Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial
Yoram Yovell, Gali Bar, Moti Mashiah, et al.
American Journal of Psychiatry (2015) Vol. 173, Iss. 5, pp. 491-498
Open Access | Times Cited: 280
Ketamine: NMDA Receptors and Beyond
Charles F. Zorumski, Yukitoshi Izumi, Steven Mennerick
Journal of Neuroscience (2016) Vol. 36, Iss. 44, pp. 11158-11164
Open Access | Times Cited: 201
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova, Anthony G. Phillips, Yu Tian Wang
Journal of Psychiatry and Neuroscience (2017) Vol. 42, Iss. 4, pp. 222-229
Open Access | Times Cited: 192
Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
Oliver H. Miller, Jacqueline Moran, Benjamin J. Hall
Neuropharmacology (2015) Vol. 100, pp. 17-26
Closed Access | Times Cited: 191
New and emerging approaches to treat psychiatric disorders
Katherine W. Scangos, Matthew W. State, Andrew H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 317-333
Closed Access | Times Cited: 76
Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression
Ji‐chun Zhang, Wei Yao, Chao Dong, et al.
Psychopharmacology (2015) Vol. 232, Iss. 23, pp. 4325-4335
Closed Access | Times Cited: 167
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Bashkim Kadriu, Laura Musazzi, Ioline D. Henter, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 119-135
Open Access | Times Cited: 147
A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial
Elias Dakwar, Edward V. Nunes, Carl L. Hart, et al.
American Journal of Psychiatry (2019) Vol. 176, Iss. 11, pp. 923-930
Open Access | Times Cited: 128
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Marc S. Lener, Bashkim Kadriu, Carlos A. Zarate
Drugs (2017) Vol. 77, Iss. 4, pp. 381-401
Open Access | Times Cited: 124
Longitudinal Effects of Ketamine on Dendritic ArchitectureIn Vivoin the Mouse Medial Frontal Cortex
Victoria Phoumthipphavong, Florent Barthas, Samantha Hassett, et al.
eNeuro (2016) Vol. 3, Iss. 2, pp. ENEURO.0133-15.2016
Open Access | Times Cited: 117
NMDAR-independent, cAMP-dependent antidepressant actions of ketamine
Nathan Wray, Jeffrey M. Schappi, Harinder Singh, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 12, pp. 1833-1843
Open Access | Times Cited: 117
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
Gerard Sanacora, Michael Johnson, Arif Khan, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 4, pp. 844-853
Open Access | Times Cited: 108
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
Francesco Bartoli, Ilaria Riboldi, Cristina Crocamo, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 77, pp. 232-236
Closed Access | Times Cited: 105
The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits
J M Witkin, James A. Monn, Darryle D. Schoepp, et al.
Journal of Pharmacology and Experimental Therapeutics (2016) Vol. 358, Iss. 1, pp. 71-82
Open Access | Times Cited: 100
A brief history of antidepressant drug development: from tricyclics to beyond ketamine
Vitor Silva Pereira, Vinicius Sato
Acta Neuropsychiatrica (2018) Vol. 30, Iss. 6, pp. 307-322
Open Access | Times Cited: 98
Classics in Chemical Neuroscience: Ketamine
Marshall Tyler, Harmony B. Yourish, Dawn F. Ionescu, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1122-1134
Closed Access | Times Cited: 96
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Brittany A. Jaso, Mark J. Niciu, Nicolas D. Iadarola, et al.
Current Neuropharmacology (2016) Vol. 15, Iss. 1, pp. 57-70
Open Access | Times Cited: 90
Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
Bangkun Yang, Jichun Zhang, Mei Han, et al.
Psychopharmacology (2016) Vol. 233, Iss. 19-20, pp. 3647-3657
Open Access | Times Cited: 89
Glutamatergic Modulators in Depression
Ioline D. Henter, Rafael T. de Sousa, Carlos A. Zarate
Harvard Review of Psychiatry (2018) Vol. 26, Iss. 6, pp. 307-319
Open Access | Times Cited: 86
Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response
Lily R. Aleksandrova, Yu Tian Wang, Anthony G. Phillips
Neuroscience & Biobehavioral Reviews (2019) Vol. 105, pp. 1-23
Closed Access | Times Cited: 82
Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature
Sandra J Drozdz, Akash Goel, Matthew W McGarr, et al.
Journal of Pain Research (2022) Vol. Volume 15, pp. 1691-1706
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top